`___________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`WOCKHARDT BIO AG,
`TEVA PHARMACEUTICALS USA, INC.,
`AUROBINDO PHARMA U.S.A., INC.,
`SUN PHARMACEUTICAL INDUSTRIES, LTD.,
`SUN PHARMA GLOBAL FZE and
`AMNEAL PHARMACEUTICALS LLC
`Petitioners,
`
`v.
`
`ASTRAZENECA AB,
`Patent Owner.
`
`
`
`Case: IPR2015-013401
`U.S. Patent No. RE 44,186
`____________________________________________
`
`ASTRAZENECA’S UPDATED MANDATORY NOTICES
`
`
`
`
`1 Petitioner Wockhardt from IPR2016-01029, Petitioner Teva from IPR2016-
`01122, Petitioner Aurobindo from IPR2016-01117, and Petitioners Sun/ Amneal
`from IPR2016-01104 have been added as Petitioners to this proceeding.
`
`
`
`
`
`Patent Owner AstraZeneca AB hereby submits Updated Mandatory Notices
`
`Case No. IPR2015-01136
`Patent 8,399,514
`
`
`pursuant to 37 C.F.R. § 42.8 to identify any other judicial or administrative matter
`
`that would affect, or be affected by, a decision in the proceeding. Specifically,
`
`Patent Owner identifies that a trial decision issued in the judicial matter,
`
`AstraZeneca AB v. Aurobindo Pharma Ltd., et al., C.A. No. 14-664-GMS on
`
`February 2, 2017.
`
`Because the Panel inquired about such a decision at the January 25, 2017, oral
`
`argument, a copy of that trial decision is attached pursuant 37 C.F.R. § 42.13(d).
`
`
`
`Dated: February 3, 2017
`
`Respectfully submitted,
`
`By: /Anthony A. Hartmann /
`
`Anthony A. Hartmann, Reg. No. 43,662
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`(202) 408-4000
`
`Counsel for Patent Owner in
`IPR2015-01340
`
`
`
`
`
`
`
`
`
`Case No. IPR2015-01136
`Patent 8,399,514
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that copies of the foregoing ASTRAZENECA’S
`
`UPDATED MANDATORY NOTICES AND ASSOCIATED ATTACHMENT
`
`were served electronically via e-mail on February 3, 2017, in its entirety to the
`
`following:
`
`Counsel for Petitioner Mylan Pharmaceuticals Inc.:
`
`Steven W. Parmelee
`sparmelee@wsgr.com
`
`Richard Torczon
`rtorczon@wsgr.com
`
`Jad A. Mills
`jmills@wsgr.com
`
`Douglas H. Carsten
`dcarsten@wsgr.com
`
`Counsel for Petitioner Wockhardt BIO AG.:
`
`
`Patrick Gallagher
`PCGallagher@duanemorris.com
`
`
`Counsel for Petitioner Teva Pharmaceuticals U.S.A., Inc..:
`
`
`Gary Speier
`gspeier@carlsoncaspers.com
`Iain McIntyre
`imcintyre@carlsoncaspers.com
`
`
`
`
`
`Counsel for Petitioner Aurobindo Pharma U.S.A., Inc..:
`
`
`Case No. IPR2015-01136
`Patent 8,399,514
`
`
`Counsel for Petitioners Sun/Amneal:
`
`
`Sailesh K. Patel
`SPatel@schiffhardin.com
`
`George Yu
`GYu@schiffhardin.com
`
`
`Samuel Park
`SPark@winston.com
`
`Andrew Sommer
`ASommer@winston.com
`
`
`
`
`
`
`
`
`
`Dated: February 3, 2017 By: /John W. Kozikowski /
`
`
`
`
`
`
`John W. Kozikowski
`
`
`
`
`
`
`
`Litigation Legal Assistant
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`
`
`
`
`
`
`
`
`
`
`
`
`
`